TY  - GEN
AU  - Shaw,D M
AU  - Connolly,N B
AU  - Patel,P M
AU  - Kilany,S
AU  - Hedlund,G
AU  - Nordle,O
AU  - Forsberg,G
AU  - Zweit,J
AU  - Stern,P L
AU  - Hawkins,R E
TI  - A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma
SN  - 0007-0920
PY  - 2007///0913
KW  - Adult
KW  - Aged
KW  - Antigens, Neoplasm
KW  - immunology
KW  - Carcinoma, Renal Cell
KW  - diagnosis
KW  - Disease Progression
KW  - Dose-Response Relationship, Drug
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Enterotoxins
KW  - administration & dosage
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Injections, Intravenous
KW  - Interleukin-2
KW  - biosynthesis
KW  - Kidney Neoplasms
KW  - Male
KW  - Membrane Glycoproteins
KW  - Middle Aged
KW  - Predictive Value of Tests
KW  - Prognosis
KW  - Recombinant Fusion Proteins
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/sj.bjc.6603567
ER  -